INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Brain & Mood desk →

1,209 studies · page 34 of 51

2011 / Narrative review

Research indicates neurobiological and phenomenological similarities between obesity and addictive disorders.

This review summarizes recent research highlighting similarities between obesity and addictive disorders at phenomenological and neurobiological levels. Neuroendocrine and imaging studies suggest a link between homeostatic appetite regulation, motivation, and reward expectancy. Additionally, neuropsychological findings indicate shared cognitive alterations that may contribute to impaired control over consumption.

Grosshans M, Loeber S, Kiefer F Addict Biol, 2011. PMID 21371174

2011 / Clinical narrative review

Evidence from randomized controlled trials does not support the use of oral DHEA therapy in postmenopausal women.

This clinical review evaluated randomized controlled trials (RCTs) through November 2010 investigating DHEA therapy in postmenopausal women with normal adrenal function. While cross-sectional studies suggested associations between low DHEA levels and impaired sexual function, well-being, and cognitive performance, placebo-controlled RCTs showed no benefits of oral DHEA for these outcomes. In addition, oral DHEA did not demonstrate favorable effects on lipids or carbohydrate metabolism.

Davis SR, Panjari M, Stanczyk FZ J Clin Endocrinol Metab, 2011. PMID 21411558

2011 / Narrative review

Vitamin D deficiency is linked to skeletal disorders and multiple chronic diseases, with recommended supplementation of at least 1000 to 2000 IU/d.

This review discusses the biological role of vitamin D and the consequences of its deficiency throughout life. Vitamin D deficiency impairs intestinal calcium and phosphate absorption, leading to pelvic deformity in early life, osteopenia, osteoporosis, and increased fracture risk. Deficiency has also been linked to higher risks of preeclampsia, cesarean delivery, multiple sclerosis, rheumatoid arthritis, types I and II diabetes, heart disease, dementia, deadly cancers, and infectious diseases. Sensible sun exposure combined with supplementation of at least 2000 IU/d for adults and 1000 IU/d for children is highlighted to maximize health.

Holick MF J Investig Med, 2011. PMID 21415774

2011 / Narrative review

Coffee consumption has been linked to potential benefits for diabetes and neurodegenerative diseases, alongside potential cardiovascular and pregnancy risks.

This review evaluates the health claims, benefits, and risk factors related to coffee and its phytochemicals such as caffeine, chlorogenic acid, caffeic acid, and cafestol. Epidemiological studies and meta-analyses show inverse correlations with diabetes mellitus, various cancers, Parkinsonism, and Alzheimer's disease. However, lipid fractions such as cafestol and kahweol can raise serum cholesterol, potentially posing coronary threats like myocardial and cerebral infarction, while excessive intake may pose risks for pregnant women or individuals with postmenopausal concerns.

Shows an association, not proof of cause and effect.

Butt MS, Sultan MT Crit Rev Food Sci Nutr, 2011. PMID 21432699

2011 / Narrative review

PCBs persist in the food supply and bioaccumulation is linked to immunological, neurological, and endocrine issues.

Polychlorinated biphenyls (PCBs) are persistent organic pollutants that bioaccumulate in individuals and remain present in foods such as fish, dairy, hamburger, and poultry. Once in the body, PCB bioaccumulation can lead to reduced infection-fighting ability, increased autoimmunity, cognitive and behavioral problems, hypothyroidism, and is linked by some research to increased rates of type 2 diabetes. Testing is available to determine exposure, and dietary measures can be enacted to increase excretion and reduce PCB half-lives in humans.

Crinnion WJ Altern Med Rev, 2011. PMID 21438643

2011 / Narrative review

Current evidence indicates no role for oral DHEA supplementation in healthy, postmenopausal women.

This review examined published literature on DHEA supplementation in postmenopausal women. Daily oral DHEA achieves serum levels seen in women in their 20s. Interventional trials show no improvement in atherosclerosis or cardiovascular risk factors, and demonstrate a lowering of HDL cholesterol levels. DHEA modestly increases bone mineral density with adjuvant therapies and improves cognition in women with mild-to-moderate cognitive impairment, but not unimpaired women; intravaginal, but not oral, DHEA improves vaginal atrophy and sexual function.

Goel RM, Cappola AR Curr Opin Endocrinol Diabetes Obes, 2011. PMID 21478748

2011 / Narrative review

Exercise compares favorably to antidepressants for mild-to-moderate depression and serves as an effective treatment alternative for anxiety disorders.

This review evaluates the role of exercise in treating depression and anxiety. Physical activity is associated with reduced symptoms of depression and anxiety, along with improved physical health, life satisfaction, cognitive functioning, and psychological well-being. Studies indicate exercise compares favorably to antidepressant medications as a first-line treatment for mild to moderate depression and improves symptoms when used adjunctively. For anxiety disorders, exercise is an effective and cost-efficient treatment alternative, though it has not been shown to reduce anxiety to the level achieved by psychopharmaceuticals.

Carek PJ, Laibstain SE, Carek SM Int J Psychiatry Med, 2011. PMID 21495519

2011 / Evidence report review / state-of-the-science summary

A review found that evidence remains insufficient to draw firm conclusions on modifiable factors and risk of Alzheimer disease.

An evidence report commissioned by AHRQ reviewed studies from 1984 to October 2009 evaluating risk factors for Alzheimer disease in adults aged 50 and older. Diabetes mellitus, hyperlipidemia in midlife, and current tobacco use were linked to increased risk, whereas Mediterranean-type diet, folic acid intake, low-to-moderate alcohol intake, cognitive activities, and physical activity were linked to decreased risk. However, the quality of evidence was graded as low for all evaluated associations, leading to the conclusion that insufficient evidence exists to support firm conclusions on any modifiable factor.

Shows an association, not proof of cause and effect.

Daviglus ML, Plassman BL, Pirzada A, et al. Arch Neurol, 2011. PMID 21555601

2011 / Roundtable summary / review

A roundtable supported reinstating vitamin B-12 biomarkers in NHANES, preferring both serum vitamin B-12 and plasma methylmalonic acid.

In July 2010, a roundtable convened to evaluate vitamin B-12 status biomarkers for NHANES, which had discontinued measuring them after 2006. The panel reviewed serum vitamin B-12, methylmalonic acid (MMA), and total homocysteine, and discussed holotranscobalamin. Members supported reinstating vitamin B-12 measures, preferring the combination of serum vitamin B-12 and plasma MMA to ensure continuity with past surveys. They also highlighted uncertainties surrounding subclinical deficiency and emphasized the need for clinical trials assessing causal links to adverse health outcomes and defining appropriate biomarker cutoffs.

Yetley EA, Pfeiffer CM, Phinney KW, et al. Am J Clin Nutr, 2011. PMID 21593512

2011 / Narrative review

Excess iron is implicated in increased cancer risk and regulating body iron stores may serve as a chemopreventive strategy.

This review discusses the balance of iron in human health, noting that iron deficiency causes anaemia while excessive iron increases cancer risk, likely via free radical generation. Iron overload-associated conditions, such as genetic haemochromatosis and endometriosis, increase cancer risks, and an epidemiological study noted that iron reduction via phlebotomy was associated with decreased cancer risks in a general population. In neurons, iron overload through ferroportin block may also be involved in Alzheimer's disease.

Shows an association, not proof of cause and effect.

Toyokuni S Free Radic Res, 2011. PMID 21615276

2011 / Narrative review

Most evidence suggests hyperhomocysteinemia is a risk factor for Alzheimer's disease onset, though findings remain conflicting.

This review summarizes epidemiological investigations, including observational studies and randomized controlled clinical trials, evaluating the relationship between hyperhomocysteinemia and Alzheimer's disease. While patients with histologically confirmed Alzheimer's disease show higher plasma homocysteine levels than controls, conflicting findings persist across studies. The authors also review in vivo and in vitro evidence on mechanisms through which hyperhomocysteinemia might influence Alzheimer's disease development.

Shows an association, not proof of cause and effect.

Zhuo JM, Wang H, Praticò D Trends Pharmacol Sci, 2011. PMID 21684021

2011 / Review

Removing artificial food dyes may improve behavior, but is not a panacea for ADHD.

This review examines the historical and renewed interest in the relationship between artificial food additives, food dyes, and ADHD symptoms. While early research by Feingold and some subsequent studies suggested dye-free diets reduce hyperactivity, more rigorous empirical studies over the following 20 years were less positive. Driven by more recent research and public concern, the British government requested food manufacturers remove most artificial food dyes in December 2009. The author concludes that while removing dyes could positively influence behavior, it is not a total cure for the multifaceted disorder.

Kanarek RB Nutr Rev, 2011. PMID 21729092

2011 / Modeling / literature-based estimation study

A modeling study estimated that doubling serum 25(OH)D levels could reduce all-cause mortality rates by 7.6% to 17.3% across global regions.

This study estimated the reduction in mortality rates across six geopolitical regions assuming serum 25(OH)D levels increase from 54 to 110 nmol/l, based on published literature on UVB, vitamin D, and disease risks. Increasing serum 25(OH)D was estimated to reduce mortality from vitamin D-sensitive diseases by 20%. Estimated reductions in all-cause mortality ranged from 7.6% for African females to 17.3% for European females, averaging 0.6% lower for males than females. Estimated life expectancy increased by 2 years across all six regions.

Grant WB Eur J Clin Nutr, 2011. PMID 21731036

2011 / Literature review

A review of neurognathostomiasis details its epidemiology, clinical presentation, neuroimaging findings, and proposes diagnostic criteria.

Researchers reviewed English-language literature on neurognathostomiasis, a foodborne zoonotic helminthic infection of the central nervous system caused by Gnathostoma spp. larvae. Although endemic to Asia and Latin America, most cases are reported from Thailand, with recent reports appearing in returned travelers in Europe. Based on epidemiology, clinical signs, neuroimaging, and laboratory findings, the authors propose diagnostic criteria for the condition.

Katchanov J, Sawanyawisuth K, Chotmongkoi V, et al. Emerg Infect Dis, 2011. PMID 21762569

2011 / Review and mathematical modeling study

Up to half of Alzheimer's disease cases worldwide are potentially attributable to seven modifiable risk factors.

This review evaluated evidence on seven modifiable risk factors for Alzheimer's disease (AD): diabetes, midlife hypertension, midlife obesity, smoking, depression, cognitive inactivity or low educational attainment, and physical inactivity. Researchers calculated population attributable risks and projected case reductions. Together, up to half of AD cases globally (17.2 million) and in the USA (2.9 million) were potentially attributable to these factors. A 10-25% reduction in all seven factors was projected to potentially prevent 1.1-3.0 million AD cases worldwide and 184,000-492,000 cases in the USA.

Shows an association, not proof of cause and effect.

Barnes DE, Yaffe K Lancet Neurol, 2011. PMID 21775213

2011 / Literature review

A review found no consistent pattern of positive associations indicating a causal link between glyphosate exposure and non-cancer health outcomes.

Authors reviewed the epidemiologic literature and biomonitoring studies to evaluate potential causal links between glyphosate exposure and non-cancer health risks. Evaluated endpoints included non-cancer respiratory conditions, diabetes, myocardial infarction, reproductive and developmental outcomes, rheumatoid arthritis, thyroid disease, and Parkinson's disease. The review found no evidence of a consistent pattern of positive associations indicating a causal relationship, with most reported associations being weak and not significantly different from 1.0.

Shows an association, not proof of cause and effect.

Mink PJ, Mandel JS, Lundin JI, et al. Regul Toxicol Pharmacol, 2011. PMID 21798302

2011 / Narrative review

A review outlines how dietary molecules, low-fat diets, and targeted nutrients may help down-regulate inflammation and support multiple sclerosis management.

This narrative review evaluates the molecular-level effects of dietary molecules on inflammatory and autoimmune processes involved in multiple sclerosis (MS). The authors note that bioactive dietary components can shift cellular metabolism from anabolism to catabolism and down-regulate inflammation through interactions with enzymes, nuclear receptors, and transcription factors. Managing gut dysbiosis and combining hypo-caloric, low-fat diets with specific vitamins, oligoelements, fish oil, and polyphenols may help slow disease progression and improve patient wellness.

Riccio P Complement Ther Med, 2011. PMID 21827937

2011 / Narrative review / commentary

A review argues that the minimum desirable serum 25-hydroxyvitamin D level should exceed 75 nmol/L rather than the IOM recommendation of 50 nmol/L.

This article examines the Institute of Medicine (IOM) recommendation to maintain serum 25-hydroxyvitamin D (25(OH)D) at or above 50 nmol/L. The author argues that 25(OH)D should preferably exceed 75 nmol/L (30 ng/mL) based on re-evaluation of bone density and osteomalacia data, evolutionary biology, clinical trials, and epidemiological links to fewer falls, better tooth attachment, less colorectal cancer, and improved depression. The author attributes reported risks of prostate cancer, pancreatic cancer, or mortality at higher latitudes to dynamic seasonal fluctuations in 25(OH)D.

Vieth R Best Pract Res Clin Endocrinol Metab, 2011. PMID 21872808

2011 / Narrative review

Neurocysticercosis presents primarily as epilepsy or hydrocephalus and can be targeted for eradication via public education and sanitary improvement.

This review summarizes the clinical manifestations, diagnosis, and treatment of neurocysticercosis (NCC), the most common parasitic disease of the human brain. Diagnosis and characterization are defined by modern CT and MRI imaging, which guide individualized therapy using anthelmintics, steroids, symptomatic medications, or surgery. Epilepsy is identified as the most frequent manifestation of parenchymal NCC, while hydrocephalus is the most frequent manifestation of meningeal NCC. The authors note that eradication of cysticercosis is an attainable goal through public education and sanitary improvements in endemic areas.

Sotelo J Curr Neurol Neurosci Rep, 2011. PMID 21915772

2011 / Narrative review

Dietary lipids and lipid oxidation products may modulate Alzheimer's disease pathophysiology.

This review summarizes recent findings regarding how dietary lipids modulate Alzheimer's disease (AD) development in animals and humans, focusing on lipid oxidation products. Oxidative breakdown products of omega-6 polyunsaturated fatty acids (PUFAs) and cholesterol (oxysterols) might promote beta-amyloid deposition, whereas omega-3 PUFAs appear to help prevent and treat AD, though high concentrations can also form oxidized derivatives. The authors suggest that maintaining an appropriate omega-3/omega-6 PUFA ratio, consuming healthy oils, fish, and antioxidants, and limiting cholesterol-containing foods may benefit clinical AD prevention strategies.

Corsinovi L, Biasi F, Poli G, et al. Mol Nutr Food Res, 2011. PMID 21954186

2011 / Narrative review

A review notes turmeric consumption may potentially help prevent chronic diseases such as cancer, though epidemiologic data remain limited.

This review provides an overview of global turmeric consumption, cancer rates across regions, and potential biochemical mechanisms of action. The authors note that curcumin, the primary therapeutic phytochemical in turmeric, has been investigated for chronic diseases including diabetes, Alzheimer's, and cancer. However, there is currently little epidemiologic information on the specific effects of dietary turmeric consumption.

Shows an association, not proof of cause and effect.

Hutchins-Wolfbrandt A, Mistry AM Asian Pac J Cancer Prev, 2011. PMID 22471448

2011 / Narrative review

A review reports that Withania somnifera (Ashwagandha) exhibits anti-stress, neuroprotective, anti-inflammatory, and anti-tumor properties across various models.

This review summarizes scientific findings on Withania somnifera (Ashwagandha). In experimental models, it increased stamina in swimming tests, prevented stress-related adrenal changes, protected against stress-induced gastric ulcers, and exhibited anti-tumor effects in animal and cell models. It demonstrated cognition-promoting effects in children with memory deficits and elderly individuals, was reported useful in neurodegenerative conditions and arthritis, and exhibited anxiolytic and GABA-mimetic actions. The authors note that large-scale studies are needed to prove clinical efficacy in stress-related disorders, neuronal disorders, and cancers.

Singh N, Bhalla M, de Jager P, et al. Afr J Tradit Complement Altern Med, 2011. PMID 22754076

2010 / Narrative review

Domoic acid from contaminated shellfish causes amnesic shellfish poisoning, and the impacts of repetitive low-level exposure remain unknown.

This review describes domoic acid, a potent neurotoxin produced by Pseudo-nitzschia diatoms that accumulates in shellfish. Human consumption of contaminated shellfish caused an outbreak of amnesic shellfish poisoning (ASP) in Canada in 1987, presenting with gastrointestinal distress, memory loss, coma, and death. Due to effective seafood monitoring programs, no documented ASP cases have occurred since 1987. However, blooms are increasing worldwide, and the potential impacts of long-term, repetitive low-level exposure in at-risk human populations are currently unknown.

Lefebvre KA, Robertson A Toxicon, 2010. PMID 19505488

2010 / Historical review

Historical review details the discovery and eradication of major neurological disorders caused by water-soluble B-vitamin deficiencies.

This historical review summarizes the discovery, clinical characterization, and prevention of major neurological disorders linked to water-soluble B-vitamin deficiencies. It covers beriberi and Wernicke-Korsakoff syndrome (thiamin), pellagra (niacin/tryptophan), neural tube defects (folate), and subacute combined degeneration of the spinal cord (vitamin B12). The review notes key milestones such as Goldberger's dietary investigations, the discovery that periconceptual folate supplementation reduces neural tube defect risk by at least 70% (with US mandatory fortification decreasing birth prevalence by 20%-27%), and the development of liver extracts and vitamin B12 therapy for pernicious anemia.

Lanska DJ Handb Clin Neurol, 2010. PMID 19892133